16/09/2025Nofence has raised $35 million in Series B fundingThe new capital is announced on the heels of the company’s recent hirings of Alex Bell as managing director in the U.S. and Eric Yates as national sales directorCompany news
01/09/2025Adele Unneberg speaking at the Nordic Climate Finance SummitThe session is called "From Mitigation to Adaptation: Applying Lessons from Climate Finance to Adaptation Investment".
05/08/2025Why did we invest in Filics?At Sandwater, we’re always on the lookout for deeply technical teams building long-term change in their industry.New investments
07/07/2025New investment in Filics Series ASandwater is excited to announce our latest investment in Filics, a Munich-based robotics company. Company news
16/06/2025Katherine Mellis to host a roundtable at the DropThe topic of the roundtable is "Food security is topping national agendas — is RegenAg the key to sustainable, resilient food systems?".
04/06/2025Jeremy Clarkson adopts Nofence's technology Nofence is part of the TV-series "Clarkson's farm".
19/05/2025Sandwater partner Torkel Engeness discusses defense technology in Shifter.noTorkel Engeness notes that the sales cycles and revenue models in the defense sector are very different from typical startups.Sandwater
03/05/2025Largest delivery of Antec’s reactors to NorwayThe first large shipment of the Antec plug flow reactors travelled to Antec's newest vest plant in Hornindal, Norway.
23/04/2025Cytovation raises $6M to advance phase 2 developmentNew funds are largely provided by existing investors, led by Sandwater.
03/04/2025Sandwater welcomes Chloe Fu and Didrik Dewan to the teamChloe and Didrik join the Sandwater investment team.Sandwater
02/04/2025Partner Tom Even Mortensen guests the Nysnø podcastMortensen discusses how to turn promising climate solutions into commercial success and the key trends in technology investments in this space.Sandwater
23/03/20251X and Nvidia announce research collaboration1X has joined forces with NVIDIA to accelerate the development of advanced humanoid robots powered by AI. Company news
23/03/2025Bioenergy innovation award to Antec BiogasAntec Biogas received this year's Bioenergy Innovation Award during the FME CenBio workshop in Amsterdam recently. Company news
17/03/2025The femtech startups to watch, according to investment director Katherine MellisSifted's "30 Femtech Startups to Watch" highlights a diverse array of European companies innovating in women's health.Sandwater
10/03/2025Sandwater welcomes Reetta Heiskanen to the teamReetta joins as Sandwater's Head of Communications and Community.Sandwater
03/02/2025New investment in Enduro Genetics’ Series ASandwater is excited to announce our latest investment into Enduro Genetics’ €12M Series A, led by SuperNova.
28/01/2025XO Life rebrands their ImpactMonitor to briteXO Life expands internationally - ImpactMonitor™ becomes brite™.
23/01/2025Cytovation's latest collaboration to advance treatment for rare cancerCytovation collaborates with Cancer Research UK and the Norwegian Cancer Society to take Cytovation’s synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinoma.
15/10/2024CMR Surgical receives U.S. FDA marketing authorizationGlobally, Versius is the second most utilized surgical robotic system, with over 26,000 surgical procedures completed.Company news
03/09/2024New investment in Soil Capital's series BSandwater is excited to announce our latest investment in Soil Capital's EUR 15m Series B, led by Trill Impact Ventures. Company news
21/08/2024New investment in XO Life’s €7m seed roundSandwater is excited to announce our latest investment, leading XO Life’s €7M Seed round with co-investors Grazia Equity, Vi Partners and Bayern Kapital.Company news
24/05/2024Farminsect announces strategic partnership with AGRAVISFarmInsect and AGRAVIS offer complete modular solutions for decentralized insect fattening facilities.
08/04/2024CardioSignal presents heart failure study resultsCardiosignal presents a new clinical modality for heart failure detection using smartphones. Company news
27/03/2024Ranchers embrace virtual fencing for greener pasturesVirtual fencing is being introduced to ranchers across the United States. Here's how it’s affected their livestock operations.
14/03/2024CardioSignal publishes a population health studyCardiosignal's whitepaper outlines strategies to enhance early detection of atrial fibrillation (AF) through scalable, digital health solutions.
23/01/2024New investment in CardioSignal's Series ASandwater is excited to announce our latest investment into Cardiosignal’s $10M Series A, led by DigiTx Partners and alongside existing investor Maki.vc.
11/01/20241X announces $100M Series BExisting portfolio company 1X today announced it has raised $100m in Series B funding with participation from EQT Ventures and other notable global investors.Company news
10/01/2024Sandwater announces successful final close of venture fund at €125MSandwater doubled the target raise and Fund I is one of the largest first-time funds ever raised in the Nordics.Sandwater
23/10/2023New investment announced into FarminsectSandwater is excited to announce our new investment into Farminsect.
11/10/2023Cytovation reports promising result from Phase 1/2a Cicilia StudyFindings confirm unique dual mechanism of action and fast-to-market target indication for potentially registrational trial.Company news
05/06/2023Cytovation raises $8 million in Series A extensionCytovation raises $8 million in Series A extension financing round for clinical advancement of CyPep-1, a first-in-class targeted tumor membrane immunotherapy.
23/03/20231X raises $23.5M in Series A2 funding led by OpenAIHumanoid robotics company 1X Technologies announces Series A2 fundraise led by OpenAI to pursue producing androids at commercial scale.Company news
03/02/2023Adele Unneberg joins the Sandwater investment teamShe will be responsible for deal sourcing, due diligence and management of active investments across Sandwater’s thematic verticals.Sandwater
28/10/2022Cytovation presents Phase I dose escalation at ESMOFirst-in-human, dose escalation Phase I trial of intratumoral CyPep-1 in patients with advanced solid tumors.
26/01/2022Cytovation raises $20 million in Series A financingCytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy.